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Abstract— Doxorubicin (Dox) is a potent chemotherapeutic 
agent used in the treatment of cancer. In the present study, 
pH responsive chitosan polymer coated Dox nanoparticle 
(Composite) was developed to investigate targeted drug 
delivery against breast cancer. The anticancer drug DOX-
ZnO QDs was loaded to the chitosan nanoparticles. The 
synthesized free and drug loaded nanoparticle were 
analyzed using Fourier transmission electron microscopy 
(FTIR) and UV-Visible spectroscopy(UV-Vis). The particle 
size was measured using Transmission Electron Microscopy 
(TEM). Further, the composite was evaluated for its 
anticancer effects. Drug release analysis showed 
significantly larger amount of drug released in acidic pH of 
5.0 compared to pH 7.4. The composite was significantly 
more cytotoxic to the breast cancer cells MCF-7 and SKBR-
3. The composite was however, less toxic to HEK-293 
human embryonic kidney cells confirming minimum side 
effects on normal cells andcytotoxic to tumor cells. DAPI 
staining showed nuclear degradation in composite treated 
breast cancer cells. The cellular uptake of the composite 
was analyzed by confocal microscopy. The composite 
induced a G0/G1 phase arrest in breast cancer cells and the 
number of colonies formed by the composite treated breast 
cancer cells formed less number of colonies compared to 
free NP.  Our results showed that our composite could 
serve as a promising therapeutic approach to improve 
clinical outcomes against various malignancies.  
Keywords— Dox-ZnO QDs, iron-oxide, chitosan, 
Nanoparticle, Apoptosis, Breast cancer.  
I. INTRODUCTION 
Chemotherapy is the most preferred treatment for various 
types of cancers; however, the low therapeutic efficacy and 
high toxicity are major drawbacks [1]. Drug resistance 
exhibited by the tumor cells is also major challenge for 
effective treatment of cancer [2]. Nowadays, there are many 
anticancer drugs applied for cancer treatment such as 
Doxorubicin, a well-known anticancer drug for treatment of 
several types of cancers including breast 
cancer.Doxorubicin, a potent anticancer drug interacts with 
DNA by intercalation and inhibition of macromolecular 
biosynthesis. This inhibits the progression of topoisomerase 
II, an enzyme which relaxes supercoils in DNA for 
transcription [3].Doxorubicin is reported to induce 
apoptosis of the cancer cells. It controls the cancer cell 
proliferation [4] .Dox is reported to induce cell cycle arrest 
at G0/G1 phase [5,6]Despite such significant anticancer 
activity, the major drawbacks are the side effects, cellular 
uptake and drug resistance of cancer cells[7,8] 
Nanotechnology based approach is growing extensively in 
recent years in every research areas such chemistry, physics, 
medicine, mechanical, optical, chemical, and electronics 
respectively[9–11]. In clinical approach, extensive research 
is carried out on nano biotechnology based applications 
predominantly diagnostic and therapeutic applications 
[12,13]. In cancer research, nanocarriers offers huge 
opportunity for anticancer drug delivery. Nanocarriers are 
developed through various organic and inorganic materials 
especially those that are bio degradable and nontoxic to 
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normal cells [14,15]. Iron oxide, an organic nanoparticle 
offers multiple applications in various fields including 
biomedical applications [16]. For clinical aspect, iron oxide 
nanoparticle is applied for different approaches such as 
imaging, targeted drug delivery and for driving the drug to 
target tissues [17]. This is due to high magnetic property 
and particle size distribution that favors iron oxide 
nanoparticle for targeted cancer drug delivery and 
hyperthermia application [18]. Also, iron oxide 
nanoparticles are biocompatible and its 1000 times smaller 
than human cells so it can easily penetrate into the cells, 
enzymes, receptor and proteins [19]. Current approaches 
focus on applying iron oxide nanoparticle for magnetically 
driven drug delivery particularly for cancer treatment [20]. 
However, the low stability and aggregating nature of 
magnetic iron oxide nanoparticles owes to the practical 
difficulties to use this as a carrier. To surmount this, surface 
modification by biocompatible materials are widely 
accepted method[21]. Chitosan is a natural, bio-degradable, 
non-toxic polymer derived from deaceylation of chitin. 
Chitosan has several reports for its clinical applications 
such as burns, wounds, nanoparticle based treatments and 
tissue regeneration [22]. 
ZnO quantum dots also finds significance for its 
applications in many areas for its attractive florescence 
properties [23]. ZnO quantum dots have superior 
florescence properties than the other semiconductors 
quantum dots. Basically semiconductor ZnO nanoparticle is 
soluble in water phase so in targeted drug delivery cancer 
treatment it is applicable for imaging and diagnostic 
properties [24]. In conventional drug delivery system have 
many issues such as the drug leakage, instability of the 
carrier etc. [25]. Hence, the modern day cancer therapy uses 
stimuli responsive drug delivery system such as pH, thermal, 
magnetic, optical, redox, etc. Among these, pH responsive 
delivery system is highly suitable for targeted drug delivery. 
Due to the acidic pH exhibited by cancer cells, change in 
pH benefits drug to be released at these sites [26].  
In this study, pH responsive polymer encapsulated 
Doxorubicin-ZnO QDs was synthesized. The composite 
characterization was performed. The composite was used 
for analyzing its cytotoxicity in MCF-7 and SKBR-3 breast 
cancer cells and also HEK-3 human embryonic kidney cells. 
The effects of the composite on cancer cell proliferation 
was also evaluated.  
 
 
 
II. MATERIALS  
Chemicals and reagents 
Chitosan, Doxorubicin hydrochloride and ZnAc2.2H2O 
were all purchased from Sigma-Aldrich (St. Louis, MO, 
USA). Iron (2) chloride tetrahydride, iron (3) chloride 
hexahydrate and ammonium hydroxide were purchased 
from Merck & Co., Inc. (West Point, PA, USA). DAPI 
(4’,6-Diamidino-2-Phenylindole, Dihydrochloride), 
Fluoromount™ Aqueous Mounting Medium, Crystal violet 
solution, Propidium iodide, DMSO, MTT (Thiazolyl Blue 
Tetrazolium Blue)were all purchased from Sigma-Aldrich 
(St. Louis, MO, USA). 
 
Cell lines 
HEK-293 human embryonic kidney cell line, human breast 
cancer cell lines MCF-7 and SKBR-3 were purchased from 
Korea Cell Line bank (South Korea). All the cells were 
grown in RPMI-1640 media supplemented with 10 % Fetal 
bovine serum (FBS) and 1% Penicillin/streptomycin. Cells 
were maintained at 37° C with 5% CO2 in a humidified 
incubator. The cells were washed with 1x Dulbecco's PBS 
and trypsinized with Trypsin-EDTA solution (1x). All the 
reagents used for cell culture were purchased from 
WELGENE (South Korea). 
 
III. METHODS 
Preparation of chitosan encapsulated iron oxide 
nanoparticle: 
Chitosan encapsulated Iron oxide nanoparticles were 
synthesized through co-precipitation method as per previous 
reports [19,27]. Accordingly, Iron (II) chloride tetra hydride 
Fe(II) 1.99 g and iron (III) chloride hexahydrate Fe (III) 
5.41 g precursors were dissolved in 100ml of water. This 
mix was transferred to five necked glass balloons provided 
with heating mantle. The solutions were mechanically 
stirred continuously. Additionally, nitrogen gas was 
continuously supplied to the five necked balloon to prevent 
oxidation. To the solution, 30ml Tripolyphosphate was 
added and NH4OH was added dropwise in order to achieve 
uniform and small sized nanoparticles. Finally, the chitosan 
coated colloidal solution was washed with deionized water.  
 
Preparation of ZnO Quantum dot 
ZnO quantum dots was prepared from ZnAc2.2H2O. 
10mmol of ZnAc2.2H2O was mixed to anhydrous ethanol 
and the solution was refluxed at 70°C for about 4h. On the 
other hand, 3mmol LiOH.2H2O precursor solution was 
dissolved in 10ml anhydrous ethanol. This precursor 
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solution was actively added into the ZnZc2.2H2O precursor 
solution to achieve the ZnO quantum dots. To this, 20ml N-
hexane was added to ZnO quantum dots solution and 
centrifuged for 10-15min. The precipitated particle was 
dissolved using anhydrous ethanol and clearing top solution 
was separated and kept for drying to obtain ZnO quantum 
dots powder. This ZnO quantum dots was dispered in N-
methylpyrrolidone and sonicated to get uniform 
suspension[28].  
 
Preparation of DOX-ZnO QDs loaded on chitosan 
NMP dispersed ZnO QDs was prepared by adding 20µl of 
3-Aminoprpyltriethoxysilane and the mixture were stitred at 
100°C for 20 min. The amine modified ZnO QDs was 
collected and washed with NMP. 1 mg of folic acid was 
dissolved in dimethyl sulfoxide (DMSO), to this 1-(3- 
dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride 
was added and stirred for 30 min, after that the amine 
functionalized ZnO QDs were added and stirred. DOX was 
mixed into the amine functionalized ZnO QDS and the 
reaction was continued for some time by continues stirring. 
Finally, ZnO-DOX mixture was transferred in to the 
chitosan coated colloid solution and continuously stirred for 
12 hours(Fig.1). 
 
Characterization of the composite 
The morphology, physical and chemical characteristics of 
the prepared composite was analyzed through different 
characterization methods such as Transmission electron 
microscopy(TEM), Fourier transmission infrared 
microscopy(FTIR), Ultraviolet -visible spectroscopy (UV-
Vis) and Photoluminescence spectroscopy (PL). 
 
Time based drug -release study: 
The Dox drug release from the carrier nanoparticle was 
investigated in time dependent manner in different buffers 
at pH 7.4 and pH 5.0 for 12 hours at 37° C. Accordingly, 1 
ml of drug loaded carrier solution was transferred to the 
dialysis membrane tube (3.5 KDa). The released drug in the 
different pH buffers was analyzed at different time intervals 
by using the UV-visible spectrometer at 480 nm. 
 
In vitro cytotoxicity assay 
Cytotoxicity was evaluated on HEK-293 human embryonic 
cells, MCF-7 and SKBR-3 breast cancer cells. Cells were 
seeded on a 96-well plate in RPMI-1640 medium with 10% 
FBS and 1% P/S at cell density of 1x104 cells per well and 
incubated overnight. Cells were treated with Doxorubicin-
loaded chitosan nanoparticles containing Dox 
concentrations at 1µM, 2µM, 3µM were mixed with RPMI-
1640 media.  After 48h incubation, cells morphology was 
taken images using Phase contrast microscope. Following 
this, 20 µl of MTT reagent was added to each well. After 4 
h of incubation in 37° C, the medium was removed and 100 
µl of DMSO was added to each well. The OD was 
measured at 570nm using Microplate reader.  
 
DAPI staining 
MCF-7 and SKBR-3 cells were seeded on a coverslip in a 
35mm dish and allowed to adhere for 24h. Cells were then 
treated with empty and doxorubicin-loaded chitosan 
nanoparticles for 48h at 37° C. The cells were fixed with 
100% methanol for 20min. Cells were washed three times 
with 1x DPBS and stained with DAPI for 20sec. The cells 
were then washed with 1x DPBS and mounted. Nuclear 
morphology was taken images using confocal laser 
scanning microscope.  
 
Cellular uptake  
Cellular uptake of doxorubicin loaded chitosan 
nanoparticles was assessed. Briefly, MCF-7 and SKBR-3 
cells were seeded on a coverslip in a 35mm dish and 
allowed to adhere for 24h. Cells were treated with Empty 
and doxorubicin-loaded chitosan nanoparticles for 48h at 37° 
C. The cells were fixed with 100% methanol for 20min. 
Following this, cells were washed three times with 1xDPBS 
and stained with DAPI for 20sec. The cells were further 
washed thrice with 1xDPBS and mounted. The cellular 
uptake of Doxorubicin was observed using confocal laser 
scanning microscope.  
 
Colony formation assay 
Breast cancer cells MCF-7 and SKBR-3 were harvested 
from log phase of growth and plated at densities of 500 cells 
in a 60mm dish. Next, 24h after plating, the medium was 
replaced with fresh medium with empty or doxorubicin-
loaded iron oxide nanoparticle. After two weeks, the cells 
were washed in 1x DPBS and fixed with 100% methanol 
for 15min. The fixed cells were further washed twice with 
1x DPBS and stained with 0.5% crystal violet for 15min at 
room temperature. The cells were washed until the stain 
was removed completely. The plated showing the number 
of colonies in the empty nanoparticle and doxorubicin-
loaded iron oxide nanoparticle treated cells were 
photographed with a digital camera.  
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Cell cycle analysis 
MCF-7 and SKBR-3 cells were seeded into 6-well plates 
and treated with empty and doxorubicin-loaded iron oxide 
nanoparticles. The cells were incubated for 48h at 37° C. 
Cells were trypsinized, centrifuged at 3000rpm for 3min. 
Cells were washed twice with ice cold 1x DPBS and fixed 
with 70% cold ethanol for 1h. Following this, cells were 
washed twice with ice cold 1x DPBS and stained with 10µl 
Propidium iodide (1mg/mL) for 30 min at 37° C in dark. 
The amount of cells in each cell cycle phase was analyzed 
using flow cytometry BD LSRFortessa Instrument.    
 
Statistical analysis 
All the experiments were performed in replicates of three. 
Results are presented as means ± standard deviations (SDs). 
Statistical significance was evaluated using the Student’s t-
test and P values of < 0.05 were considered significant. 
 
IV. RESULTS AND DISCUSSION 
Morphology analysis 
The size and shape of iron oxide nanoparticle was analyzed 
using TEM. Results showed the total size of the particle 
approximately 30 nm and the shape of the particle 
expressed irregularly arranged iron oxide nanoparticle (Fig. 
2a). Approximately 90% of the iron oxide nanoparticle 
revealed needle like nano rods similar to the previous 
reports [29]. The morphology and size of the ZnO QDs 
appeared sphere like quantum dots structure and size of the 
QDs is approximately 8-10nm (Fig. 2b). 
 
Analysis of chemical composition of composite using 
FTIR 
FTIR analysis was done for chitosan, iron oxide + chitosan, 
free Dox and Dox loaded with Iron oxide and Zinc oxide 
nanoparticles. Simple Iron oxide and ZnO showed band at 
560 cm-1 and 463 cm-1 indicating the Fe-O and Zn-O 
stretching. Bands at 3369 cm-1 and 1630 cm-1and the 
absence of band at 560 cm-1 in INP-Chitosan composite 
confirms the encapsulation of iron oxide by chitosan.  The 
observed FTIR band for free DOX assigned as follow, 3454 
& 2920 cm-1and band at1410 cm-1 is due to the presence of 
C-C, and at 1046 cm-1is due to C-O. In Dox loaded 
composite nanoparticles, FTIR spectrum peak is shifted to 
3386 cm-1due to overlapof N-H and O-H peaks and showed 
broader peaks at 2901 cm-1 (C-H) ,1408 cm-1 (C-C) and 
1020 cm-1 (C-O). These peaks confirmed successful loading 
of Dox in the composite. Iron showed absorption peak at 
560 cm-1and ZnO quantum dots at 461 cm-1in FTIR 
spectrum (Fig. 3). 
 
UV-Visible spectrometry analysis of the composite 
The UV-Visible analysis of the free Dox and Dox loaded 
composite nanoparticle was analyzed by the UV-Visible 
spectrometer. Free Dox exhibited the two major peaks at 
234nm and 487 nm. However, the composite showed peak 
shift at 256 nm and 570nm. Also the composite peak 
exhibited a slight hump peak at 358nm exhibiting the 
presence of ZnO (Fig. 4). These results confirmed that Dox 
was successfully loaded in the composite. These results 
further confirmed the FTIR results.  
 
Photoluminescence 
Photoluminescence spectrum of the ZnO quantum dot and 
composite nanoparticle showed multiple emission peaks. 
ZnO quantum emission attribute at 376nm 408 and 558nm. 
The peak 376nm denoted ZnO QDs. The peak at 558nm 
denoted the oxygen vacancy level. Composite nanoparticle 
also showed three major peaks at 366 ,422 and 580nm 
respectively. The peak at 366nm exhibit ZnO QDs peak 
shift from 376nm to 366nm in the composite. Chitosan peak 
was seen at 422nm and finally DOX emission peak was 
seen at 580nm (Fig. 5). 
 
Drug release from carrier nanoparticle 
The DOX drug released from the carrier nanoparticle in 
different pH levels at 37°C in different pH buffered solution 
at pH 5.0 and pH 7.4 is shown in (Fig. 6). Maintaining the 
temperature at 37°C mimics the normal physiological 
temperature. Poor drug release was observed at pH 7.4 at 12 
hours but at pH 5.0 the drug released was nearly 80%. The 
release study suggested the carrier was completely acidic 
pH responsive thus releasing the drug at acidic pH. 
 
The cytotoxicity of Doxorubicin- loaded iron oxide 
nanoparticles 
MTT assay was performed to determine the cytotoxicity of 
Doxorubicin-loaded iron oxide nanoparticles. Dox 
concentrations ranging from 1µM to 3µM was treated to 
HEK-239 embryonic kidney cells and MCF-7 and SKBR-3 
breast cancer cells. The percentage of viable cells after 48h 
of treatment was calculated (Fig. 7 a, b).  Doxorubicin when 
introduced as nanoparticle composites to the cells, is shown 
to confer less toxicity to the normal cells. There are 
previous reports that Doxorubicin-loaded colloidal 
nanoassembles confer less cytotoxicity compared to direct 
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treatment with Doxorubicin in NIH3T3 mouse fibroblast 
cells [30]. Corresponding to this, our results from MTT 
assay showed Doxorubicin-loaded iron oxide nanoparticles 
induced cytotoxicity to the MCF-7 and SKBR-3 breast 
cancer cells at specific concentrations. However, HEK-293 
human embryonic kidney cells were not affected at the 
same concentrations. Thus the composite can be effective in 
inducing cytotoxicity to the cancer cells while leaving the 
normal cells unharmed The results confirmed a significant 
cytotoxicity of the composite containing Dox concentration 
at 3µM in MCF-7 and SKBR-3 breast cancer cells. On the 
other hand, this concentration did not show any cytotoxicity 
to HEK-293 cells.  
 
Cellular uptake analysis using CSLM 
The cellular uptake of Dox was assessed by CSLM. The 
nucleus is stained with DAPI and cellular uptake of Dox 
was seen as red fluorescence inside cells. The intensity of 
the red fluorescence was also seen to be increased in the 
cells whose nuclear morphology is changed indicating 
apoptosis in these cells induced by Dox (Fig. 8). The most 
important criteria for developing different drug-loaded 
nanoparticle composites is increased cellular uptake by the 
cancer cells [31] The mechanism through which chitosan 
encapsulated nanoparticles enter the cancer cells are 
discussed extensively. The most common being endocytosis.  
[32] The particles are endocytosed into human cancer cells, 
drug is then released and increases cytotoxicity than free 
drug. Images from the CSLM of the composite treated 
MCF-7 and SKBR-3 breast cancer cells showed immense 
cellular uptake of the composite 48h after treatment.  
 
Doxorubicin-loaded iron oxide nanoparticles induce 
nuclear breakage 
Condensed and fragmented nuclei are characteristics of 
apoptosis. MCF-7 and SKBR-3 breast cancer cells treated 
with Doxorubicin-ZnO QDs loaded chitosan nanoparticles 
for 48h were subjected to DAPI staining. The nuclear 
morphology of the empty nanoparticle treated and 
Doxorubicin NP treated cells was evaluated using Confocal 
microscope. The morphology of the cells treated with empty 
nanoparticle remained intact and regular. On the other hand, 
nuclear condensation and abnormal nucleus are seen in 
Doxorubicin-loaded chitosannanoparticles indicating cell 
apoptosis (Fig. 9). Similar to these results, changes in 
nuclear morphology of cancer cells upon Dox treatment is 
previously reported. MCF-7 and SKBR-3 breast cancer 
cells treated with the composite showed similar nuclear 
degradation as observed in confocal images upon DAPI 
staining. There are several reports on different molecular 
mechanisms underlying this [33].  
 
Doxorubicin-loaded chitosan nanoparticles control the 
cell proliferation of breast cancer cells 
One important feature of Doxorubicin is the regulation of 
cancer cell proliferation. To confirm the regulation of breast 
cancer cell proliferation by the composite, colony formation 
assay was performed. MCF-7 and SKBR-3 breast cancer 
cells were treated with empty and composite for 48 h and 
the number of colonies formed was evaluated after two 
weeks. MCF-7 and SKBR-3 cells treated with empty NP 
formed many colonies. On the other hand, MCF-7 and 
SKBR-3 cells treated with composite formed significantly 
less number of colonies than empty NP treated cells. These 
results indicate that composite controls the breast cancer 
cell proliferation (Fig. 10 a). Dox treatment is reported to 
control the cell proliferation of many types of cancer cells 
such as colon, lung, liver, breast, etc.[34][4]. Here, we have 
shown that our composite could appreciably reduce the cell 
proliferation.  
 
Doxorubicin-loaded chitosannanoparticles induce G1 
phase arrest in breast cancer cells 
Besides apoptosis, our composite also inducted cell cycle 
arrest in breast cancer cells. MCF-7 and SKBR-3 breast 
cancer cells were treated with empty NP and composite. 
48h after treatment, cells were subjected to Propidium 
iodide (PI) staining and flow cytometry analysis was used to 
determine the cell cycle distribution. MCF-7 and SKBR-3 
breast cancer cells treated with composite showed a 
significant reduction of cells in G0/G1 phase compared to 
the empty NP treated cells (Fig.10 b).  
 
V. CONCLUSION 
In summary, DOX-ZnO QDs loaded with the chitosan 
nanoparticles were successfully developed and evaluated 
for their anticancer effects. The composite was nanosized at 
around 30nm and with uniform needle like nano rods 
morphology. The drug was loaded to the shell effectively. 
Drug release analysis showed significantly larger amount of 
drug released in acidic pH of 5.0 compared to pH 7.4. The 
composite induced significant cytotoxicity only to MCF-7 
and SKBR-3 but very less toxic to HEK-293 cells at 
particular concentrations emphasizing cytotoxic effect 
against breast cancer cells specifically. The cellular uptake 
of the composite in the breast cancer cells were quite 
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significant. The composite also induced nuclear damage 
upon treatment. The proliferation of the breast cancer cells 
drastically decreased compared to the control. Further, the 
composite induced cell cycle arrest at the G1 phase in these 
cells. Based on our results, we believe that our composite 
can effectively kill the breast cancer cells in vitro and needs 
for more in vivo studies in future to translate this approach 
into the clinic (Fig.11). Iron oxide in the composite 
facilitates driving the composite to cancer cells specifically 
using magnetic field and ZnO quantum dots can act as a dye 
for imaging purpose in in vivo models. Additionally, there 
are several reports on the anticancer properties of ZnO 
therefore this Dox-ZnO QDs formulation will have higher 
anticancer effect compared to other Dox formulations. 
Hence, as a next step, we intend to continue the effective 
targeted therapy of the composite against breast cancer in 
xenograft models.    
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Fig.1: Schematic diagram showing preparation of Dox-ZnO QDs and subsequent loading of Dox-ZnO QDs to Chitosan 
nanoparticles. 
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Fig.2: TEM images. (a) iron oxide nanoparticle, (b) ZnO QDs. 
 
 
 
Fig.3: FTIR spectrum of the empty nanoparticle, composite and free DOX. (a) chitosan alone, (b) Iron oxide+ chitosan, (c) 
composite, (d) free DOX, (e) ZnO QDs. 
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Fig.4: Absorption spectra of the DOX and DOX loaded nanoparticle. (a) Iron oxide, (b) Chitosan, (c) ZnO QDs, (d) free DOX, (e) 
Composite. 
 
 
 
Fig.5: Fluorescence spectra. (a) ZnO QDs, (b) DOX loaded composite nanoparticle. 
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Fig.6.: pH dependent release of DOX from DOX-ZnO QDs loaded chitosan nanoparticles. DOX release studies were carried 
out by calculating the amount of DOX in acetate (pH 5.0) and phosphate (pH 7.4) buffer dialysis filtrate at different time 
intervals. 
 
 
 
Fig.7: In vitro antitumor cytotoxic effect of various concentrations of Dox in the composite in HEK-293 human embryonic kidney 
cells, MCF-7 and SKBR-3 breast cancer cells after 48h incubation. (a) Cell death observed using phase contrast microscope. (b) 
percentage of viable cells using MTT assay. Each value represents the mean ±SE (n=5). 
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Fig.8: In vitro cellular uptake of the composite by MCF-7 and SKBR-3 breast cancer cells after incubation for 48h. The cells 
were observed using confocal laser scanning microscopy (DAPI: blue, Dox: red). 
 
 
 
Fig.9: Nuclear damage of MCF-7 and SKBR-3 breast cancer cells. Cells were treated with indicated concentrations of composite 
for 48h. The cells were fixed, nucleus was stained and observed using confocal laser scanning microscopy (DAPI: blue). 
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Fig.10: (a) Composite inhibited cell proliferation of breast cancer cells. (a) MCF-7 and SKBR-3 cells were treated with 
indicated concentrations of composite for 48h. Clonogenic assay was performed to validate colony formation ability of treated 
cells. (b) Cell cycle analysis was performed after treating MCF-7 and SKBR-3 cells with indicated concentrations of composite 
for 48h using flow cytometry. 
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Fig.11: Schematic illustration of mechanism for the interaction of ZnO QDs-breast cancer cells and their cytological death. 
 
